Sertraline vs Escitalopram: Differences in Side Effects, Dosing and Uses

Sertraline (Zoloft) and escitalopram (Lexapro) are both SSRIs. They have the same boxed warning and many of the same side effects, and in the largest network meta-analysis the differences between antidepressants for depression were small. Where they differ is in their FDA-approved uses, how the dose is adjusted, which side effects show up most in the trials, and how they interact with other medicines. Sertraline is approved for a wider range of conditions, including OCD, PTSD and PMDD. Escitalopram has a simpler dose range and is approved for generalized anxiety disorder.

Neither one is better for everyone. The choice depends on your diagnosis, your other medicines, your heart and liver health, how you or close relatives have done on SSRIs before, and which side effects you most want to avoid. This article lays out the label facts so you can have a better-informed conversation with your prescriber. It is not a guide to choosing or switching on your own.

The short version: how the two compare

What each drug is FDA-approved to treat

An FDA-approved indication means the manufacturer ran trials that convinced the FDA the drug works for that condition. Prescribers also use both drugs off-label, which is legal and common, but the evidence behind an off-label use varies, so it is worth asking what it is based on.

Sertraline

The Zoloft label lists six indications: major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder. In children and teens, safety and effectiveness have been established only for OCD, from age 6 through 17. For PMDD, the label allows either daily dosing or dosing only during the two weeks before a period. That flexibility is one reason sertraline comes up so often in PMDD treatment decisions.

Escitalopram

The Lexapro label lists two indications: major depressive disorder in adults and adolescents 12 and older, and generalized anxiety disorder in adults and children 7 and older. Using escitalopram for panic disorder, social anxiety or OCD is off-label in the United States. Off-label does not mean wrong, but your prescriber should be able to explain the reasoning.

If your main problem is OCD or PTSD, sertraline has the approved indication. If it is generalized anxiety, escitalopram does. For depression alone, both are approved and the decision usually turns on other factors. For OCD in particular, see how medication fits with exposure therapy.

How well do they work?

The best-known comparison is a 2018 network meta-analysis in The Lancet by Cipriani and colleagues. It pooled 522 double-blind trials with 116,477 adults with major depression and compared 21 antidepressants. Every antidepressant was more effective than placebo.

Two findings from that analysis bear directly on this comparison:

• In head-to-head trials, escitalopram was among the drugs that came out more effective than other antidepressants.
• For acceptability, measured as dropping out of a trial for any reason, both escitalopram and sertraline were among the better-tolerated drugs.

The analysis has real limits. The authors rated the certainty of the evidence as moderate to very low, and differences between individual drugs were small, with wide uncertainty on most comparisons. The trials were of acute treatment in adults with depression, so they say little about anxiety disorders, long-term use, or how any one person will respond. A ranking in a meta-analysis is not a reason to switch from a drug that is working for you.

Dosing: how each is started and adjusted

Dosing is the prescriber's decision. The ranges below come from the FDA labels and are here so you know what to expect, not so you can adjust your own dose.

Sertraline has a wide range. The label allows increases of 25 to 50 mg a day, about once a week, up to 200 mg a day. That gives the prescriber many steps to find a dose that works and is tolerable, but it can also mean more visits before you reach the right dose.

Escitalopram has a narrow range. In a fixed-dose depression trial, 20 mg a day was no more effective than 10 mg. Many people stay on 10 mg, and the label caps the dose at 20 mg.

Both drugs stay in the body long enough to be taken once a day, and both labels say to reduce the dose gradually rather than stop suddenly when possible. If you are thinking about stopping, talk to your prescriber first. The article on switching antidepressants explains cross-tapering and what discontinuation symptoms feel like.

Side effects: where they overlap and where they differ

Most side effects of the two drugs overlap, because they work the same way. The labels list the reactions that appeared in at least 5% of trial patients and at least twice as often as on placebo.

Sertraline: more stomach and bowel effects

For sertraline, those reactions were nausea, diarrhea or loose stool, tremor, indigestion, decreased appetite, excess sweating, ejaculation failure and decreased libido. The prominence of diarrhea and indigestion is why sertraline is often described as harder on the stomach. These effects tend to be strongest in the first weeks; the site's guide to managing SSRI digestive side effects covers practical steps to discuss with your prescriber.

Escitalopram: more sleep and energy effects

For escitalopram, the list was insomnia, ejaculation disorder (mainly delayed ejaculation), nausea, increased sweating, fatigue, sleepiness, decreased libido and anorgasmia. The label also reports that side effects were more frequent at 20 mg than at 10 mg in two fixed-dose trials.

Sexual side effects

Both labels list sexual side effects among the most common. The Lexapro label notes that labeling estimates probably underestimate how often they occur, partly because patients and clinicians may be reluctant to discuss them. Raise them early; there are options, and stopping the medicine on your own is not one of them. More detail is in the site's guide to SSRI sexual side effects.

Warnings that apply to both

• Suicidal thoughts and behaviors: both carry a boxed warning about increased risk in children, adolescents and young adults, and both labels call for close monitoring for worsening, especially early on and after dose changes.
• Bleeding: both drugs can increase the risk of bleeding, and the risk adds up with aspirin, NSAIDs such as ibuprofen, and blood thinners such as warfarin.
• Low sodium: both labels warn about hyponatremia, and the Lexapro label notes that older adults may be at greater risk.
• Mania: both labels say to screen for a personal or family history of bipolar disorder before starting. An SSRI alone can trigger a manic or mixed episode in someone with bipolar disorder.
• Serotonin syndrome: both are contraindicated with MAOI antidepressants, with a 14-day gap required in either direction.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

The heart rhythm (QT) question

People often hear that escitalopram "affects the heart." The concern comes mostly from its parent drug, citalopram (Celexa). The Celexa label describes dose-dependent QT prolongation, says doses above 40 mg a day are not recommended, and caps the dose at 20 mg a day for people over 60, people with liver impairment and CYP2C19 poor metabolizers. Escitalopram is the S-enantiomer, a single mirror-image form, of citalopram, so the question carries over.

The Lexapro label reports a dedicated heart-rhythm study in healthy volunteers. The largest mean QT increase over placebo was 4.5 milliseconds at 10 mg and 10.7 milliseconds at a supratherapeutic 30 mg dose, with a predicted 6.6 milliseconds at the 20 mg maximum. In the ECG comparison from the label's placebo-controlled trials, no patient on escitalopram had a QT interval over 500 milliseconds. QT prolongation has been reported after marketing.

Sertraline is not free of this concern either. Its label added a QTc warning: cases of QTc prolongation and torsade de pointes have been reported after marketing, and a dedicated study found QTc rose with blood levels, so the label advises caution in people with risk factors.

In practice, the QT question matters most if you have a heart rhythm condition, low potassium or magnesium, or take other QT-prolonging drugs (some antibiotics, antipsychotics, antiarrhythmics and methadone, for example). Tell your prescriber about all of these. They may check an ECG or electrolytes, or choose a different drug.

Drug interactions

The two drugs differ most in how they interact with other medicines.

• Sertraline inhibits CYP2D6, a liver enzyme that clears many drugs; the label's examples include some heart rhythm drugs, beta-blockers such as metoprolol, the tricyclic desipramine, antipsychotics such as perphenazine, atomoxetine and venlafaxine. Its label says the dose of a CYP2D6 substrate may need to be lowered when sertraline is added, and raised if sertraline is stopped.
• Escitalopram is broken down mainly by CYP3A4 and CYP2C19. Because more than one enzyme handles it, blocking a single enzyme may not raise levels much. It has a modest CYP2D6 effect: in one study it doubled the exposure to desipramine, which led the label to advise caution with drugs that use that pathway.
• Both are contraindicated with pimozide. Sertraline oral solution contains alcohol and must not be used with disulfiram.
• Both raise bleeding risk with aspirin, NSAIDs and anticoagulants.

If you take several medicines, this is often the deciding factor. Bring a full list, including supplements, to every visit; the guide on preparing your medication history has a template. Alcohol is its own question, covered in psychiatric medications and alcohol.

Which situations tend to favor which drug

These are patterns prescribers often weigh, not rules. Your prescriber will look at your whole history.

Pregnancy and breastfeeding are separate decisions with their own evidence; see psychiatric medications during pregnancy before making any change.

If the first one does not work

An SSRI usually needs several weeks at an adequate dose before you can judge it. If one drug fails or is not tolerated, prescribers commonly try a different SSRI, a different class, or a combination. Moving from sertraline to escitalopram or the reverse is a reasonable step for some people, but it should be planned with your prescriber, not done by stopping one bottle and starting another. For a broader view, see how a first antidepressant is chosen and fluoxetine vs sertraline. For the first weeks on any SSRI, the site's guide to the first two weeks on an SSRI covers what is common and what to report.

Questions to ask your prescriber

• Is my diagnosis an FDA-approved use for this drug, or would this be off-label?
• Do any of my other medicines interact with it, especially through CYP2D6 or bleeding risk?
• Do I need an ECG or blood test before starting, given my heart history or age?
• What side effects should I expect in the first two weeks, and which ones should I call about?
• How long should I give this dose before we decide whether it is working?
• If I want to stop someday, how would we taper?

How Dr. Lewis's practice approaches medication choices

The practice's psychiatrists and psychiatric nurse practitioners provide psychiatric evaluation and medication management, alongside psychotherapy, including CBT and DBT, coaching, lab testing, and nutrition and lifestyle psychiatry. If you are weighing sertraline, escitalopram or a change from one to the other, a free discovery call by phone or text is the first step to ask about care options, scheduling and insurance. The practice is out of network with all insurance plans and provides superbills for possible out-of-network reimbursement; fees are listed on the insurance and payment page. If you need care that is in network with your plan, ask the team on the discovery call about options. More on how SSRIs fit into a broader plan is in the Choosing Psychiatric Care guide and on the medication management page.

Frequently asked questions

Is escitalopram stronger than sertraline?

Not in a meaningful sense. The dose numbers are not comparable because the drugs differ in potency. In the 2018 Lancet network meta-analysis, both beat placebo for depression; escitalopram was among the drugs that did better in head-to-head trials and sertraline was not, but the differences were small and the evidence was rated moderate to very low certainty.

Can I take sertraline or escitalopram for anxiety even though only one is approved for my type?

Prescribers often use SSRIs off-label for anxiety disorders outside their approved list. That is legal and common. Ask your prescriber what evidence supports the off-label use for your specific condition.

Which one causes more weight gain?

Neither label lists weight gain among the most common side effects in the trials, and long-term weight data are limited. Weight change on an SSRI varies by person. If it happens, raise it with your prescriber rather than stopping the drug.

Do I need an ECG before starting escitalopram?

The Lexapro label does not call for a routine ECG before starting. One may be considered if you have a heart rhythm condition, low potassium or magnesium, take other QT-prolonging drugs, or are older. Your prescriber decides based on your history.

Can I switch from sertraline to escitalopram on my own if I have side effects?

No. Both labels advise gradual dose reduction rather than abrupt stopping, and switching between SSRIs needs a plan for timing and dose. Call your prescriber about side effects; many can be managed without switching.

Are generic sertraline and escitalopram the same as Zoloft and Lexapro?

FDA-approved generics contain the same active ingredient. Some people notice differences when a pharmacy changes manufacturers; the guide to generic vs brand-name psychiatric medications explains what is and is not known.

Sources

1. ZOLOFT (sertraline hydrochloride) tablets and oral solution, prescribing information. Viatris Specialty LLC / U.S. National Library of Medicine DailyMed, 2025. dailymed.nlm.nih.gov
2. LEXAPRO (escitalopram) tablets, prescribing information. U.S. National Library of Medicine DailyMed, 2024. dailymed.nlm.nih.gov
3. CELEXA (citalopram) tablets, prescribing information. Allergan / U.S. National Library of Medicine DailyMed, 2026. dailymed.nlm.nih.gov
4. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet (Cipriani A, et al.), 2018. pubmed.ncbi.nlm.nih.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.